| Literature DB >> 31277058 |
Abstract
Desmoplastic infantile ganglioglioma (DIG) is a rare, distinctive, supratentorial neoplasm with a generally favorable prognosis. Clinical, radiographic, and pathologic features can sometimes mimic those of a malignant tumor and other serious intracranial disorders. The author describes his experience with 3 cases of DIG, each of which initially masqueraded as another neurological disease with a very different prognosis. Case 1 was an infant boy referred for evaluation of a hemorrhagic infarction at birth. Case 2 was an infant girl referred for evaluation of a holohemispheric malignant neoplasm. Case 3 was an infant girl referred for evaluation of an intracranial mass believed to be a subdural empyema or possible sarcoma. In each case the lesion was resected and found to be a WHO grade I DIG. Each child has had a benign postoperative course. DIG can be mistaken for other serious neurological conditions including malignant neoplasm, cerebral infarction, and infection. It is prudent to consider this rare, low-grade resectable tumor in the differential diagnosis of atypical intracranial masses of childhood, as the impact on prognosis can be profound. The author discusses management strategies for DIG, including a role for molecular sequencing.Entities:
Keywords: BRAF; CBC = complete blood count; DIA = desmoplastic infantile astrocytoma; DIG = desmoplastic infantile ganglioglioma; GFAP = glial fibrillary acidic protein; MRI; NAA = N-acetylaspartate; brain tumor; desmoplastic infantile ganglioglioma; diagnosis; next generation sequencing; oncology
Year: 2019 PMID: 31277058 DOI: 10.3171/2019.5.PEDS19151
Source DB: PubMed Journal: J Neurosurg Pediatr ISSN: 1933-0707 Impact factor: 2.375